Tenon Medical, Inc. 8-K

What Happened

• On February 25, 2026, Tenon Medical, Inc. (NASDAQ: TNON) announced it received a Notification Letter from the Nasdaq Listing Qualifications Staff stating its common stock failed to maintain the minimum $1.00 closing bid price for the 30 consecutive business-day period from January 9, 2026 through February 24, 2026.
• Nasdaq has given the company an initial 180-calendar-day compliance period, ending August 24, 2026, to regain compliance. To do so the stock must have a closing bid of at least $1.00 for a minimum of 10 consecutive business days during that period.
• The notice does not affect the current listing; TNON will remain listed and tradable on The Nasdaq Capital Market while the company evaluates options to regain compliance.

Key Details

• Period of deficiency: January 9, 2026 – February 24, 2026 (30 consecutive business days).
• Compliance deadline: August 24, 2026 (initial 180-day period).
• Regain threshold: $1.00 closing bid for at least 10 consecutive business days.
• Possible next steps: if not compliant, Tenon may be eligible for a second 180-day period only if it meets Nasdaq’s market value and other initial listing standards (except the bid-price rule) and notifies Nasdaq it intends to cure the deficiency—potentially by a reverse stock split.

Why It Matters

• For investors, failure to regain compliance could lead to delisting from Nasdaq, which typically reduces liquidity, makes trading more difficult, and can negatively affect share value.
• The company may pursue actions (including a reverse split) to meet the $1.00 requirement; such actions would directly affect share counts and investor holdings.
• There is no immediate trading impact—TNON remains listed—but the outcome of the compliance period is material and could influence short- and long-term investor decisions. The filing also notes forward-looking statements and uncertainty about whether Tenon will regain compliance.